{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T16:23:43Z","timestamp":1722702223924},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,10]]},"DOI":"10.7759\/cureus.8547","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T11:57:27Z","timestamp":1591790247000},"source":"Crossref","is-referenced-by-count":0,"title":["Cerebral Toxoplasmosis in a Rheumatoid Arthritis Patient on Immunosuppressive Therapy"],"prefix":"10.7759","author":[{"given":"Brittany","family":"Hill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2012.693197","article-title":"A review on human toxoplasmosis","volume":"44","author":"Saadatnia G","year":"2012","unstructured":"Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012, 44:805-814. 10.3109\/00365548.2012.693197","journal-title":"Scand J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux F","year":"2012","unstructured":"Robert-Gangneux F, Dard\u00e9 ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012, 25:264-296. 10.1128\/CMR.05013-11","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis","volume":"114","author":"Halonen SK","year":"2013","unstructured":"Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013, 114:125-145. 10.1016\/B978-0-444-53490-3.00008-X","journal-title":"Handb Clin Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.50.252","article-title":"Case of toxoplasma encephalopathy with specific MRI findings diagnosed by IgG avidity index and nested PCR. (Article in Japanese)","volume":"50","author":"Horiuchi K","year":"2010","unstructured":"Horiuchi K, Yabe I, Tajima Y, Kondo T, Takizawa Y, Yamada H, Sasaki H. Case of toxoplasma encephalopathy with specific MRI findings diagnosed by IgG avidity index and nested PCR. (Article in Japanese). Rinsho Shinkeigaku. 2010, 50:252-256. 10.5692\/clinicalneurol.50.252","journal-title":"Rinsho Shinkeigaku"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0139-17","article-title":"Cerebral toxoplasmosis diagnosed by nested-polymerase chain reaction in a patient with rheumatoid arthritis","volume":"57","author":"Matsuura J","year":"2018","unstructured":"Matsuura J, Fujii A, Mizuta I, Norose K, Mizuno T. Cerebral toxoplasmosis diagnosed by nested-polymerase chain reaction in a patient with rheumatoid arthritis. Intern Med. 2018, 57:1463-1468. 10.2169\/internalmedicine.0139-17","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc051556","article-title":"Infliximab and reactivation of cerebral toxoplasmosis","volume":"353","author":"Young JD","year":"2005","unstructured":"Young JD, McGwire BS. Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med. 2005, 353:1530-1531. 10.1056\/NEJMc051556","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.3977","article-title":"Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis","volume":"54","author":"Pulivarthi S","year":"2015","unstructured":"Pulivarthi S, Reshi RA, McGary CT, Gurram MK. Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis. Intern Med. 2015, 54:1433-1436. 10.2169\/internalmedicine.54.3977","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket364","article-title":"Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis","volume":"53","author":"Nardone R","year":"2014","unstructured":"Nardone R, Zuccoli G, Brigo F, Trinka E, Golaszewski S. Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis. Rheumatology (Oxford). 2014, 53:284. 10.1093\/rheumatology\/ket364","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev115","article-title":"Toxoplasmosis in immunosuppressed patients","volume":"54","author":"Lewis JM","year":"2015","unstructured":"Lewis JM, Clifford S, Nsutebu E. Toxoplasmosis in immunosuppressed patients. Rheumatology (Oxford). 2015, 54:1939-1940. 10.1093\/rheumatology\/kev115","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203407","article-title":"Non-viral opportunistic infections in new users of tumor necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study","volume":"73","author":"Baddley JW","year":"2014","unstructured":"Baddley JW, Winthrop KL, Chen L, et al.. Non-viral opportunistic infections in new users of tumor necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study. Ann Rheum Dis. 2014, 73:1942-1948. 10.1136\/annrheumdis-2013-203407","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001124","article-title":"Atypical ocular toxoplasmosis during adalimumab anti-tumor necrosis factor therapy for rheumatoid arthritis (Epub ahead of print)","author":"Walkden A","year":"2019","unstructured":"Walkden A, Wig S, Bhatt PR, Jones NP, Steeples LR. Atypical ocular toxoplasmosis during adalimumab anti-tumor necrosis factor therapy for rheumatoid arthritis (Epub ahead of print). J Clin Rheumatol. 2019, 10.1097\/RHU.0000000000001124","journal-title":"J Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00108-019-00727-6","article-title":"Neurological symptoms in a patient on anti-TNF therapy, methotrexate and prednisolone for rheumatoid arthritis. (Article in German)","volume":"61","author":"Bach M","year":"2020","unstructured":"Bach M, Schob S, Baerwald C. Neurological symptoms in a patient on anti-TNF therapy, methotrexate and prednisolone for rheumatoid arthritis. (Article in German). Internist (Berl). 2020, 61:313-320. 10.1007\/s00108-019-00727-6","journal-title":"Internist (Berl)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006545","article-title":"Toxoplasmosis seroprevalence in rheumatoid arthritis patients: a systematic review and meta-analysis","volume":"12","author":"Hosseininejad Z","year":"2018","unstructured":"Hosseininejad Z, Sharif M, Sarvi S, et al.. Toxoplasmosis seroprevalence in rheumatoid arthritis patients: a systematic review and meta-analysis. PloS Negl Trop Dis. 2018, 12:e0006545. 10.1371\/journal.pntd.0006545","journal-title":"PloS Negl Trop Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34008-cerebral-toxoplasmosis-in-a-rheumatoid-arthritis-patient-on-immunosuppressive-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:13Z","timestamp":1707506773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34008-cerebral-toxoplasmosis-in-a-rheumatoid-arthritis-patient-on-immunosuppressive-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.8547","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,10]]}}}